Zimmer Biomet Holdings Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 106 trades in Zimmer Biomet Holdings Inc (NYSE: ZBH) since 2016, across 11 members, worth an estimated $1.7M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 59 buys against 47 sells, a modestly buy-led skew, with Democratic members responsible for 82% of the trades and Republican members 18%. The most recent disclosure shown was filed April 2026, and Ro Khanna has filed the most ZBH transactions among those shown, with 16. One notable disclosed move was a purchase by Ro Khanna on November 3, 2025, down 14.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Zimmer Biomet Holdings Inc (ZBH) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Zimmer Biomet Holdings congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Ro Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | SELL |  $1,001 - $15,000 | -2.95% | |
Ro Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | SELL | $1,001 - $15,000 | -12.29% | |
Ro Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | BUY | $1,001 - $15,000 | -12.29% | |
Ro Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $1,001 - $15,000 | -3.97% | |
Ro Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $15,001 - $50,000 | -0.94% | |
Ro Khanna House | Feb 6, 2026 | Jan 23, 2026 | 14 days | BUY | $1,001 - $15,000 | -1.60% | |
Ro Khanna House | Feb 6, 2026 | Jan 14, 2026 | 23 days | BUY | $1,001 - $15,000 | -4.52% | |
Ro Khanna House | Feb 6, 2026 | Jan 13, 2026 | 24 days | BUY | $1,001 - $15,000 | -3.54% | |
Ro Khanna House | Dec 8, 2025 | Nov 10, 2025 | 28 days | SELL | $1,001 - $15,000 | -3.71% | |
Ro Khanna House | Dec 8, 2025 | Nov 6, 2025 | 32 days | BUY | $1,001 - $15,000 | -3.47% |
Zimmer Biomet Holdings (ZBH) congressional trading FAQ
Can members of Congress legally trade Zimmer Biomet Holdings (ZBH) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Zimmer Biomet Holdings (ZBH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Zimmer Biomet Holdings (ZBH) trades public?
Yes. Every congressional trade in Zimmer Biomet Holdings (ZBH) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Zimmer Biomet Holdings (ZBH)?
Members of Congress have disclosed 106 trades in Zimmer Biomet Holdings (ZBH) worth $1.7M across 11 members, according to public STOCK Act filings.
Which members of Congress have traded Zimmer Biomet Holdings (ZBH)?
Recent and active filers of Zimmer Biomet Holdings (ZBH) disclosures include Ro Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Zimmer Biomet Holdings (ZBH) more?
Across disclosed Zimmer Biomet Holdings (ZBH) trades, 82% were by Democrats and 18% by Republicans, led by Democrats (82%).
What is the most recent congressional Zimmer Biomet Holdings (ZBH) trade?
The most recent disclosed Zimmer Biomet Holdings (ZBH) trade was a sale by Ro Khanna, filed Apr 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewZimmer Biomet Holdings (ZBH) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.